Clinical Trial Update: A Safety and Efficacy Study of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 safety and efficacy study of STSP-0601 in adult patients with Hemophilia A or B with inhibitors has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• STSP-0601 (STSP-0601)

Snippet

Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd | Conditions: Hemophilia | Phase 1, Phase 2 | Status: COMPLETED